Aurora Cannabis Inc. · TSX:ACB
Aurora Cannabis — Q1 2025 Earnings Presentation
16 slides from Aurora Cannabis's earnings presentation, Aug 7, 2024
Slide 1: Investor Presentation August 2024
INVESTOR PRESENTATION AUGUST 2024
Slide 2: Disclaimer
Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information contained in this presentation constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this presentation that are not statements of historical fact may be deemed
Slide 3: Diversified Global Business Model
Diversified Global Business Model Focus on Defensive, Stable, High Margin Segments International Canadian Medical Plant Propagation Adult Recreational Science & Innovation Medical #1 Canadian Medical Controlling interest in Bevo, one of Ability to deliver products Delivering a continuous stream shar
Slide 4: Leading Global Cannabis Platform
Leading Global Cannabis Platform • Global medical cannabis net revenue(1) reached a record $47.2m in Q1, up 13% compared to the prior year period. • Increased revenue primarily attributable to increasing sales in Canada, Australia, and Germany • Adjusted gross margins(1) for medical cannabis consist
Slide 5: Leadership in Key Global Cannabis Markets
Leadership in Key Global Cannabis Markets UNITED KINGDOM: 68m population • Solid market position through relationships with POLAND: 40m population key distributors and supply of Channel Islands; a high-growth market due to less rigid prescriber • Rapidly growing medical market regulations • Aurora c
Slide 6: Canadian Medical Leadership
Canadian Medical Leadership Aurora is leading the market with 4 owned brands and a wide variety of marketplace offerings Consistent Revenue Stream and Margin Leader • #1 Canadian Medical Share by revenue; ~7% revenue(1) growth year over year Value Core • Direct-to-patient controlled distribution mod
Slide 7: Latest Medical Innovations
Latest Medical Innovations Dried Flower Lotions & Topicals Oils & Capsules Edibles & Beverages Vapes & Concentrates • Esprit de Corps Extra Strength CBD isolate • CBD 50 Max 3000 Drops • 2:1 CBN, CBD Berry Gummies • Strawberry & Peach Vape • Courage THC Free lotion • CBN Night formula • CBD Peach Pl
Slide 8: A Compelling Portfolio of Adult Recreational Brands
A Compelling Portfolio of Adult Recreational Brands Core Alternative Premium Super Premium Maximum Flavour, Maximum Potency, High-THC edibles for the Proprietary genetics with unique aromas Exceptional true-to-cultivar, craft offerings. Brand Promise Maximum Value modern-day consumer in a range of s
Slide 9: Sales and Marketing Support
Sales and Marketing Support Ongoing national campaign focused on maximizing brand and product Innovation will be communicated to retailers via national e-mail and in- awareness, further enhancing purchase consideration for Tasty's Vapes. store pitches. They will be supported by a full suite of digit
Slide 10: MedReleaf Australia Acquisition
MedReleaf Australia Acquisition Aurora has been partnered with MedReleaf Australia, the #2 distributor of medical cannabis products in Australia, since 2017. In February 2024, Aurora acquired the remaining approximately 90% equity interest of MedReleaf Australia. The acquisition makes Aurora the lar
Slide 11: Plant Propagation Overview
Plant Propagation Overview • Aurora holds a controlling interest in Bevo Farms, an industry leader in plant propagation and one of the largest suppliers of propagated vegetables and ornamental plants in North America. • Bevo is cash flow positive on an annualized basis and contributed record revenue
Slide 12: Science & Innovation Program
Science & Innovation Program A state-of-the-art breeding facility in Vancouver Island’s Comox Valley: • Built specifically to find the next big genetics: high yielding, high cannabinoid strains with unique terpene flavours and distinctive experiences • Delivered 19 new proprietary cultivars, grown a
Slide 13: Key Takeaways
Key Takeaways Opening the Largest global medical cannabis company in nationally legal markets World to Diversified and growing footprint in high-margin medical cannabis markets across the globe Cannabis Consistent sequential and year-over-year revenue growth, including record global medical re
Slide 14: Senior Management Team
Senior Management Team Miguel Martin Director & CEO Miguel’s career spans nearly 30 years in consumer- packaged goods, covering various regulated categories and fast-moving markets. Miguel is the former CEO & President of Reliva. Simona King Nathalie Clark Alex Miller Chief Financial Officer EVP, Ge
Slide 15: Board of Directors
Board of Directors Ronald Funk Miguel Martin Chairman Director & CEO Ron brings over 30 years of Miguel’s career spans nearly experience in business and 30 years in consumer- consulting and has worked with packaged goods, covering clients in a range of industries, various regulated categories includ
Slide 16: Investor Presentation
INVESTOR PRESENTATION Email: aurora@icrinc.com Website: auroramj.com/investors